Personally I do not foresee a BUYOUT of the company IPIX , More likely see a BUYOUT of IPIX's drug BRILACIDIN for BIG BUCKS if anything. That would , for the first time leave the company in a HUGE CASH position to concentrate on advancing KEVETRIN to FDA approval and getting a revenue stream. .